日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

First-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIRE I Study

首次在人体试验中应用新型完全可重新定位的IMPERIA输送系统，将ALLEGRA经导管心脏瓣膜植入重度钙化性主动脉瓣狭窄或退化的外科生物瓣膜患者：EMPIRE I研究的30天结果

期刊:Structural Heart
影响因子:2.8
doi:10.1016/j.shj.2024.100391
Antonio Baz, José; Burgdorf, Christof; Frerker, Christian; Cruz González, Ignacio; Antoni Gômez, Joan; Graham, Joseph; Maria Hernândez, José; Jimenez, Pilar; Ren, Claire B; Spitzer, Ernest; Tonino, Pim; Vriesendorp, Pieter; van Mieghem, Nicolas; Copt, Samuel; Jönsson, Anders; Oldroyd, Keith G; Doll, Nicolas
Human
MPI
发表日期：2025
文献求助 收藏

Safety and Effectiveness of a Novel Microcatheter in Coronary Chronic Total Occlusions-The BIOMICS Study

新型微导管治疗冠状动脉慢性完全闭塞的安全性和有效性——BIOMICS 研究

期刊:
影响因子:
doi:10.1016/j.jscai.2024.102017
Sidik, Novalia; McEntegart, Margaret; Joshi, Francis; Owens, Colum; Shaukat, Aadil; Gallagher, Sean; Strange, Julian; Tang, Kare; Elghamaz, Ahmed; Mozid, Abdul; Ladwiniec, Andrew; Oldroyd, Keith; Schuette, Diana; Copt, Samuel; Spratt, James C
发表日期：2024
文献求助 收藏

Angina After Percutaneous Coronary Intervention: Patient and Procedural Predictors

经皮冠状动脉介入治疗后心绞痛：患者和手术相关预测因素

期刊:Circulation-Cardiovascular Interventions
影响因子:7.4
doi:10.1161/CIRCINTERVENTIONS.122.012511
Collison, Damien; Copt, Samuel; Mizukami, Takuya; Collet, Carlos; McLaren, Ruth; Didagelos, Matthaios; Aetesam-Ur-Rahman, Muhammad; McCartney, Peter; Ford, Thomas J; Lindsay, Mitchell; Shaukat, Aadil; Rocchiccioli, Paul; Brogan, Richard; Watkins, Stuart; McEntegart, Margaret; Good, Richard; Robertson, Keith; O'Boyle, Patrick; Davie, Andrew; Khan, Adnan; Hood, Stuart; Eteiba, Hany; Berry, Colin; Oldroyd, Keith G
发表日期：2023
文献求助 收藏

Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects

Brolucizumab治疗新生血管性年龄相关性黄斑变性和糖尿病性黄斑水肿：眼科和糖尿病治疗方面

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-023-00647-7
Garweg, Justus G; Blum, Claudine A; Copt, René-Pierre; Eandi, Chiara M; Hatz, Katja; Prünte, Christian F; Seelig, Eleonora; Somfai, Gábor M
糖尿病
代谢
发表日期：2023
文献求助 收藏

Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR)

支架植入后血流储备分数与冠状动脉造影在经皮冠状动脉介入治疗优化中的比较（TARGET-FFR）

期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehab449
Collison, Damien; Didagelos, Matthaios; Aetesam-Ur-Rahman, Muhammad; Copt, Samuel; McDade, Robert; McCartney, Peter; Ford, Thomas J; McClure, John; Lindsay, Mitchell; Shaukat, Aadil; Rocchiccioli, Paul; Brogan, Richard; Watkins, Stuart; McEntegart, Margaret; Good, Richard; Robertson, Keith; O'Boyle, Patrick; Davie, Andrew; Khan, Adnan; Hood, Stuart; Eteiba, Hany; Berry, Colin; Oldroyd, Keith G
发表日期：2021
文献求助 收藏

Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients

在学术研究联盟定义的出血高风险患者中，药物涂层支架与裸金属支架的比较

期刊:EuroIntervention
影响因子:9.5
doi:10.4244/EIJ-D-20-00749
Marquis-Gravel, Guillaume; Urban, Philip; Copt, Samuel; Capodanno, Davide; Pocock, Stuart J; Sadozai Slama, Sara; Stoll, Hans-Peter; Tanguay, Jean-François; Mehran, Roxana; Leon, Martin B; Rao, Sunil V; Morice, Marie-Claude; Krucoff, Mitchell W
发表日期：2021
文献求助 收藏

Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes

薄支架钴铬合金可生物降解聚合物Biolimus A9洗脱支架与厚支架不锈钢可生物降解聚合物Biolimus A9洗脱支架：两年临床结果

期刊:Journal of Interventional Cardiology
影响因子:1.7
doi:10.1155/2021/6654515
Menown, Ian B A; Mamas, Mamas A; Cotton, James M; Hildick-Smith, David; Eberli, Franz R; Leibundgut, Gregor; Tresukosol, Damras; Macaya, Carlos; Copt, Samuel; Slama, Sara Sadozai; Oldroyd, Keith G
发表日期：2021
文献求助 收藏

Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial

经皮冠状动脉介入治疗和1个月双联抗血小板治疗后出血风险高的患者中基于性别的结局：LEADERS FREE随机临床试验的二次分析

期刊:Jama Cardiology
影响因子:14.1
doi:10.1001/jamacardio.2020.0285
Mehran, Roxana; Chandrasekhar, Jaya; Urban, Philip; Lang, Irene M; Windhoevel, Ute; Spaulding, Christian; Copt, Samuel; Stoll, Hans-Peter; Morice, Marie-Claude
血小板
发表日期：2020
文献求助 收藏

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study

Biolimus-A9 无聚合物涂层支架在高出血风险急性冠脉综合征患者中的应用：一项 Leaders Free ACS 子研究

期刊:European Heart Journal
影响因子:35.6
doi:10.1093/eurheartj/ehw203
Naber, Christoph K; Urban, Philip; Ong, Paul J; Valdes-Chavarri, Mariano; Abizaid, Alexandre A; Pocock, Stuart J; Fabbiocchi, Franco; Dubois, Christophe; Copt, Samuel; Greene, Samantha; Morice, Marie-Claude
发表日期：2017
文献求助 收藏

Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)

阿他西普预防中重度系统性红斑狼疮（SLE）患者病情发作的疗效和安全性：52 周数据（APRIL-SLE 随机试验）

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2013-205067
Isenberg, David; Gordon, Caroline; Licu, Daiana; Copt, Samuel; Rossi, Claudia Pena; Wofsy, David
APR
红斑狼疮
免疫/内分泌
发表日期：2015
文献求助 收藏